Element Squared LLC Sells 733 Shares of McKesson Corporation $MCK

Element Squared LLC decreased its position in McKesson Corporation (NYSE:MCK) by 21.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,681 shares of the company’s stock after selling 733 shares during the quarter. Element Squared LLC’s holdings in McKesson were worth $2,199,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of MCK. GGM Financials LLC bought a new stake in McKesson during the third quarter valued at approximately $25,000. State of Wyoming bought a new position in McKesson in the second quarter worth approximately $29,000. Hopwood Financial Services Inc. bought a new position in McKesson in the third quarter worth approximately $31,000. Vermillion & White Wealth Management Group LLC purchased a new position in shares of McKesson during the 3rd quarter worth $33,000. Finally, Board of the Pension Protection Fund bought a new stake in shares of McKesson during the 4th quarter valued at $33,000. 85.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at McKesson

In other news, EVP Leann B. Smith sold 190 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the completion of the transaction, the executive vice president directly owned 2,989 shares in the company, valued at approximately $2,824,605. This represents a 5.98% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The SEC filing for this sale provides additional information. Insiders sold 3,868 shares of company stock valued at $3,743,820 in the last 90 days. 0.08% of the stock is currently owned by insiders.

Analysts Set New Price Targets

MCK has been the subject of several analyst reports. TD Cowen upped their price objective on McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Raymond James Financial set a $970.00 price target on McKesson in a report on Thursday, March 5th. JPMorgan Chase & Co. upped their price target on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Barclays raised their price objective on McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 18th. Finally, Evercore reiterated an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $960.93.

McKesson Stock Performance

MCK stock opened at $885.42 on Friday. The company’s fifty day moving average price is $912.57 and its 200-day moving average price is $844.55. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00. The company has a market capitalization of $108.45 billion, a PE ratio of 25.46, a price-to-earnings-growth ratio of 1.26 and a beta of 0.42.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the previous year, the firm posted $8.03 EPS. McKesson’s revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 1st. Investors of record on Monday, March 2nd were given a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Monday, March 2nd. McKesson’s payout ratio is currently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.